Lunes 08:00 - 17:00 Martes 08:00 - 17:00 Miércoles 08:00 - 17:00 Jueves 08:00 - 17:00 Viernes 08:00 - 17:00

CytoImmune Therapeutics

Casa
Puerto Rico
Toa Baja
CytoImmune Therapeutics

We are a clinical-stage biopharmaceutical company in Puerto Rico focused on the development and comm
(1)

TRACK-NK™ and Coalescent™ Cell Clinical Pipeline

CytoImmune Therapeutics is a clinical-stage biotechnology company, developing a novel class of cancer immunotherapy medicines based on engineered, allogeneic, tumor-reactive natural killer (TRACK-NK™) cell therapies for patients with cancer. The cells are engineered to both directly attack cancer cells and broadly stimulate both the innate and adap

tive arms of the immune system through potent IL-15 secretion. This dual mechanism of action of the TRACK-NK™ cells is achieved through proprietary manufacturing methods and engineering the expression of secreted IL-15, chimeric antigen receptors (CAR), and the secretion of a bispecific killer engager (BiKE) molecule, enabling both dual antigen targeting and broad immune stimulation in one engineered cell. The company is headquartered in Monrovia, CA with al manufacturing facility for cells and virus in Puerto Rico.

Dirección

Carrera 865 KM 5. 4 Int, Expreso José De Diego, Candelaria Arenas
Toa Baja
00949

Horario de Apertura

Lunes	08:00 - 17:00
Martes	08:00 - 17:00
Miércoles	08:00 - 17:00
Jueves	08:00 - 17:00
Viernes	08:00 - 17:00

Página web

https://www.cytoimmune.com/contact-us/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando CytoImmune Therapeutics publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.